PAVM PAVMED INC Investments/Divestments 8-K Filing 2024 - Investment Agreement Pavmed Inc.'s majority owned subsidiary, Lucid Diagnostics, entered into subscription agreements with investors for the sale of Series B-1 Preferred Stock, raising approximately $11.6 million.Get access to all SEC 8-K filings of the PAVMED INC